DOSING OF INTRAVENOUS GANCICLOVIR FOR THE PROPHYLAXIS AND TREATMENT OF CYTOMEGALOVIRUS INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS1

Autor: Fishman, Jay A., Doran, Maureen T., Volpicelli, Sheila A., Cosimi, A. Benedict, Flood, James G., Rubin, Robert H.
Zdroj: Transplantation; February 2000, Vol. 69 Issue: 3 p389-394, 6p
Abstrakt: The optimal regimen for the prevention and treatment of cytomegalovirus (CMV) disease in solid organ transplant recipients remains to be defined, particularly for patients with abnormal or changing renal function.
Databáze: Supplemental Index